COMMUNIQUÉS West-GlobeNewswire

Merit Medical to Present at Three Conferences in May

30/04/2018 - 15:25

SOUTH JORDAN, Utah, April 30, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI ), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and [...]

New Data Demonstrate the Biodesix VeriStrat® Liquid Biopsy Test Reliably Informs Lung Cancer Treatment Decisions

30/04/2018 - 15:20

- First Data Showing Prognostic Value of Test Among Patients by Performance Status Presented at ACMQ Annual Meeting – - Optimizing Best Supportive Care and Avoiding Overtreatment Creates an Expected Savings of $955 Per [...]

Summary of capital reduction pursuant to Article 32 of the Danish Capital Markets Act

30/04/2018 - 15:06

Read the full announcement in the attached file Attachment 2018_20_Reduction_of_common_stock_EN

NewLink Genetics to Participate in Upcoming Investor Conferences

30/04/2018 - 15:00

AMES, Iowa, April 30, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK ) announced today that the company will participate in the following investor conferences: Deutsche Bank 43 rd Annual Health Care [...]

athenahealth to Present at the Deutsche Bank 43rd Annual Health Care Conference

30/04/2018 - 15:00

WATERTOWN, Mass., April 30, 2018 (GLOBE NEWSWIRE) -- athenahealth, Inc. (NASDAQ: ATHN ), a leading provider of network-enabled services for hospital and ambulatory clients nationwide, today announced that Tim O’Brien, [...]

Arbutus Announces Conference Call to Provide a Corporate Update and First Quarter 2018 Financial Results

30/04/2018 - 15:00

VANCOUVER, British Columbia and WARMINSTER, Pa., April 30, 2018 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS ), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today [...]

Neochord DS1000 System Successfully Treats 20th Patient in Combination with Other Beating Heart Procedures

30/04/2018 - 15:00

Nearly 1,000 patients treated with the DS1000 System Reports acceleration in two transcatheter mitral repair programs ST. LOUIS PARK, Minn., April 30, 2018 (GLOBE NEWSWIRE) -- NeoChord, Inc. , a privately-held medical [...]

Tabula Rasa HealthCare Subsidiary CareKinesis Signs Agreement with SpiriTrust Lutheran LIFE

30/04/2018 - 14:30

MOORESTOWN, N.J., April 30, 2018 (GLOBE NEWSWIRE) -- CareKinesis, a subsidiary of Tabula Rasa HealthCare (NASDAQ: TRHC ), a healthcare technology company advancing the field of medication safety, recently signed an [...]

Alder BioPharmaceuticals® to Host Conference Call to Discuss First Quarter 2018 Financial and Operating Results

30/04/2018 - 14:30

BOTHELL, Wash., April 30, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR ), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]

Grandevo® CG and Venerate® CG Approved for Use on Cannabis by the Colorado, Washington and Nevada Departments of Agriculture

30/04/2018 - 14:30

Grandevo and Venerate are Effective Tools for Controlling Mites and Insect Pests DAVIS, Calif., April 30, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI), a leading provider of bio-based [...]

Yield10 Bioscience to Host Webcast of its First Quarter 2018 Conference Call

30/04/2018 - 14:30

WOBURN, Mass., April 30, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ), a Company developing new technologies to achieve step-change improvements in crop yield that enhance global food security, [...]

Ultragenyx and Kyowa Kirin Announce Crysvita® (burosumab-twza) Now Launched in the U.S. for the Treatment of X–linked Hypophosphatemia (XLH) in Children and Adults

30/04/2018 - 14:30

First FDA-Approved Treatment that Targets the Underlying Cause of this Rare, Hereditary, Lifelong Disease UltraCare™ Program in Place to Provide Ongoing Patient Support NOVATO, Calif., TOKYO and LONDON, April 30, 2018 ( [...]

Avinger’s Next Generation Pantheris Featured in Live Case Transmission at Charing Cross International Symposium 2018

30/04/2018 - 14:30

Charing Cross Symposium (CX) is the longest running vascular and endovascular symposium in Europe and one of the largest in the world REDWOOD CITY, Calif., April 30, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ: AVGR [...]

Cytori Provides Update on US Manufacturing and EU Approval Plans for ATI-0918, Liposomal Doxorubicin

30/04/2018 - 14:30

SAN DIEGO, April 30, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (Nasdaq: CYTX ) (“Cytori” or “the Company”) today provided an update on its plans for US manufacturing and EU approval for its ATI-0918 liposomal [...]

Acology Secures Canadian Patent for MedTainer™

30/04/2018 - 14:30

CORONA, Calif., April 30, 2018 (GLOBE NEWSWIRE) -- Acology Inc. (OTCMARKETS:ACOL) announced today that their signature product, the MedTainer, has been granted a Utility Patent from the Canadian Intellectual Property [...]

Imaging3 Announces Appointment of George Zdasiuk to Board of Directors

30/04/2018 - 14:30

Former CTO of Varian Medical Systems will also chair Imaging3 Scientific Advisory Board BURBANK, Calif., April 30, 2018 (GLOBE NEWSWIRE) -- Imaging 3 , Inc. (OTCQB:IGNG), a development stage company introducing [...]

Cellular Biomedicine Group Announces Results of 2018 Annual Meeting of Stockholders

30/04/2018 - 14:30

SHANGHAI, China and CUPERTINO, Calif., April 30, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc . (NASDAQ: CBMG ) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in the development of [...]

Syneos Health Launches Catalyst Ophthalmology Site Network to Support Faster Start Up and Efficient Trial Delivery

30/04/2018 - 14:15

New Network Builds on Success of the Company’s Early Phase, Oncology, Psychiatry and Vaccine Catalyst Site Networks RALEIGH, N.C., April 30, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq: SYNH ), the only fully [...]

Genocea Files Investigational New Drug Application for Neoantigen Cancer Vaccine Candidate GEN-009

30/04/2018 - 14:04

- C ompany plans to initiate Phase 1/2a clinical program later this year - - Top-line immune response data expected in the first half of 2019 - CAMBRIDGE, Mass., April 30, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, [...]